C, A Tetracycline (Tet)-inducible, shRNA-resistant USP22 transgene was stably introduced into HCT116 cells. Cells were treated as in A, with and without expression of the transgene via Tet treatment. Whole-cell lysates were subjected to immunoblotting with the indicated antibodies. 